Ultrasound Procedures

Clinical Decision Making

Before selecting ultrasound, a PTA must confirm that modalities are listed in the physical therapy plan of care (POC). It is common to simply see "modalities" checked in the plan of care without any stipulated treatment parameters.

A PTA must, therefore, be able to review the plan of care, identify an impairment (e.g., pain, soft tissue restriction, ROM restriction, edema, skin integrity) and select the most appropriate treatment parameters based on the patient case.

Patient communication is an essential component of effective ultrasound treatment. A PTA should ask the patient about any previous experience with ultrasound and confirm informed consent to the proposed treatment prior to applying ultrasound. A screen of precautions and contraindications may be indicated depending on the information a PTA can derive from the PT's initial evaluation. A patient may disclose a medical condition (e.g., cancer) to the PTA which was previously unknown to the PTA.

Any patient disclosure of a precaution or contraindication to ultrasound which is not reflected in the medical record shall result in immediate communication to the supervising PT before initiating treatment. If a PTA has questions about the safety and effectiveness of a prescribed modality in a POC, the PTA shall seek clarification from the supervising PT prior to administering the modality

A PTA must also be continuously monitoring the tissue and the patient in order to make timely treatment modifications as needed.

A PTA must also recognize signs of equipment malfunction. PTAs monitor clinical ultrasound equipment for signs of wear and tear, including integrity of electrical cords and the transducer . A PTA can place the sound head underwater at an angle to the surface and increase intensity to 1.0 W/cm2. Water should lightly ripple/displace, indicating an active sound head. A biomedical inspection should occur at least annually.

 

Dosages

 

Temp Increase

Tissue Effect

1°C

Increases metabolism, reduces mild inflammation

3.6-5.4°C

 

Reduces pain and muscle spasm; increases blood flow

7.2°C

 

Increases ROM and tissue extensibility (in combination with stretching and exercise)

 

 

 

Ultrasound Parameters.JPG

 

Redrawn from Cameron MH: Physical Agents in Rehabilitation: From Research to Practice, ed 2, St. Louis, 2002, WB Saunders.

 

Keep in mind that the effective radiating area (ERA) is determined by the manufacturer of the clinical unit. The ERA is determined by the type and integrity of the crystal in the transducer (sound head). In general, the treatment area is generally about twice the size of the transducer in order to produce thermal and non-thermal effects.

Tissue Properties

 

 

Documentation

Essential elements of documentation include:

 

Sample note - 10/19/18 11:00-11:35

S: Patient reports modest changes in R hip pain from in her bursitis area. Pain is 6/10 with activity, like walking. Unable to walk > 2 blocks due to hip pain.

O: Pt consent to US: Pain to palpation R trochanter bursa 6+/10. Applied US 0.6 W/cm2 @ 1 MHz, 50% x 6 min to bursa, followed by gentle soft tissue mobilization abductor strengthening activities in partial WB. Instructed in HEP for PWB functional abductor strengthening exercises (see handout). Pain with palpation decreased to 4/10 after US application

A: US appears beneficial in reducing pain, allowing for manual stretching and progressing HEP with stable pain levels.

P: Continue with POC, assess pain response and functional changes next visit

Layne Coledge, SPTA